Schedule iii

By

21 Aug 2026

Cannabis ETF Surges as Trulieve's NYSE Debut Signals Sector Shift

Shares of the AdvisorShares Pure US Cannabis ETF (MSOS) have climbed to their highest levels of 2026, with investors positioning ahead of a June 29 DEA administrative hearing that could reshape how

• MSOS ETF

By

29 Jun 2026

Federal Rescheduling Hearing Puts Cannabis Operators and Compliance on Notice

The DEA opened formal proceedings Monday on a proposal to move marijuana from Schedule I to Schedule III of the Controlled Substances Act - the most consequential federal drug policy proceeding in

• DEA

By

11 May 2026

DOJ Moves to Reschedule Cannabis, Reshaping Federal Policy for U.S. Operators

The U.S. Department of Justice announced Thursday it would immediately ease restrictions on state-regulated medical marijuana products and fast-track proceedings to reclassify cannabis more broadly -

• DOJ

By

03 May 2026

Federal Rescheduling of Medical Marijuana Opens the Door to International Trade

Effective April 28, 2026, the United States formally acknowledged medical marijuana as a legitimate controlled substance by moving it to Schedule III of the Controlled Substances Act - a shift that

• medical marijuana

By

03 May 2026

Trump Executive Order Pushes Cannabis Rescheduling Forward, Threatening 280E's Grip

On December 18, 2025, President Donald J. Trump signed an Executive Order directing the Attorney General to finalize the rulemaking that would move marijuana from Schedule I to Schedule III of the

• Trump executive order